Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus-2009-2010

被引：0
|
作者：
Skrahina, Alena [1 ]
Khaliaukin, Andrei [2 ]
Falzon, Dennis [3 ]
Rusovich, Valiantsin [4 ]
Dara, Masoud [5 ]
Shyrayeu, Aliaksandr [2 ]
Zhylevich, Liudmila [6 ]
Zignol, Matteo [3 ]
Hurevich, Hennadz [1 ]
机构：
[1] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS
[2] Gomel Reg TB Hosp, Gomel, BELARUS
[3] World Hlth Org, STOP TB Dept, Geneva, Switzerland
[4] World Hlth Org, Country Off, Minsk, BELARUS
[5] World Hlth Org, Reg Off Europe, Copenhagen, Denmark
[6] Minist Hlth, Gen Directorate Med Care, Minsk, BELARUS
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Tuberculosis; -; management; MDR-TB; Monitoring;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2570
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
    Skrahina, Alena
    Hurevich, Henadz
    Zalutskaya, Aksana
    Sahalchyk, Evgeni
    Astrauko, Andrei
    Hoffner, Sven
    Rusovich, Valiantsin
    Dadu, Andrei
    de Colombani, Pierpaolo
    Dara, Masoud
    Van Gemert, Wayne
    Zignol, Matteo
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
    Gualano, Gina
    Urso, Rocco
    Silvia, Rosati
    Roberto, Tonnarini
    Daniele, Biagioli
    Giuseppe, Matteucci
    Piero, Ghirga
    Silvia, Murachelli
    Antonino, Di Caro
    Gianluigi, Biava
    Delia, Goletti
    Enrico, Girardi
    Giuseppe, Ippolito
    Nicola, Lauria Francesco
    Fabrizio, Palmieri
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [3] Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
    Ali, Monadil H.
    Alrasheedy, Alian A.
    Hassali, Mohamed Azmi
    Kibuule, Dan
    Godman, Brian
    ANTIBIOTICS-BASEL, 2019, 8 (03):
  • [4] Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications
    Ali, Monadil H.
    Alrasheedy, Alian A.
    Kibuule, Dan
    Godman, Brian
    Hassali, Mohamed Azmi
    Ali, Hamdan Mustafa Hamdan
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (11) : 927 - 937
  • [5] Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)
    Field, Stephen K.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 137 - 149
  • [6] Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)
    Bonnet, Maryline
    Bastard, Mathieu
    Du Cros, Philipp
    Atadjan, Khamraev
    Kimenye, Kamene
    Khurkhumal, Shazina
    Hayrapetyan, Armen
    Telnov, Alex
    Hewison, Cathy
    Varaine, Francis
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [7] The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB)
    Palacios, E
    Guerra, D
    Llaro, K
    Chalco, K
    Sapag, R
    Furin, J
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (04) : 343 - 346
  • [8] Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
    Satria A. Prabowo
    Matthias I. Gröschel
    Ed D. L. Schmidt
    Alena Skrahina
    Traian Mihaescu
    Serap Hastürk
    Rotislav Mitrofanov
    Edita Pimkina
    Ildikó Visontai
    Bouke de Jong
    John L. Stanford
    Père-Joan Cardona
    Stefan H. E. Kaufmann
    Tjip S. van der Werf
    Medical Microbiology and Immunology, 2013, 202 : 95 - 104
  • [9] Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Sabur, Natasha F.
    Brar, Mantaj S.
    Wu, Lisa
    Brode, Sarah K.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [10] Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Natasha F. Sabur
    Mantaj S. Brar
    Lisa Wu
    Sarah K. Brode
    BMC Infectious Diseases, 21
12345